// STATE LEGISLATION TRACKER

Missouri HB 11: Modifies provisions relating to abortion

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Missouri
Bill: HB 11
Filed: 2022-09-20
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Missouri HB 11 is an abortion bill, not a peptide or pharmacy-compounding bill. Based on the title and available bill text, it does not appear to change access to compounded peptides, off-label peptide prescribing, telehealth peptide care, NP or naturopath peptide scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

No peptide-specific prescribing limits are identified.
No 503A or 503B compounding changes are identified.
No telehealth rules for peptide care are identified.
No NP or naturopath scope changes for peptides are identified.
The bill is about abortion regulation, not peptide access.

What to Watch For

Note Do not treat this as a peptide access bill unless later amendments add pharmacy, prescribing, or compounding language.

Note Clinicians who also provide reproductive care may need separate review, but peptide workflows are not directly affected.

Where the Bill Stands

The bill was from Missouri's 2022 first extraordinary session, which has ended, and no enactment was identified in the available source.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws